Packaging
Pfeiffer and Valois Pharma announce resounding success for the 4th Indian Nasal and Pulmonary Drug Delivery Symposium focused on “Regulatory Challenges: a Perspective”
Monday 28. September 2009 - In association with the Indian Pharmaceutical Association, Pfeiffer and Valois Pharma, world leaders in nasal and pulmonary drug delivery devices, co-organized, through Aptar Pharma India, the Fourth International Symposium on Nasal and Pulmonary Drug Delivery, held in Mumbai, India, on September 17th and 18th, 2009.
Regulatory Challenges, a topical theme for this mature Indian conference
The first such Indian scientific conference tailored specifically to Nasal and Pulmonary Drug Delivery was held in 1999. Now a mature event, this years symposium saw more than 125 paying delegates attending fifteen presentations over the two days, with major participation of scientists and technical experts from Indias pharmaceutical industry and academia. Speakers included globally-recognized international experts such as Prof. Richard Dalby, from Maryland University in the U.S. and Jag Shur from the University of Bath in the U.K.
This years event focused on Regulatory Challenges, as the Indian Pharma Industry has shown great interest over the years in introducing drug products to highly regulated markets like the US and Europe.
A major scientific contribution from Pfeiffer and Valois Pharma
The program was structured into three sessions: podium presentations and scientific posters covering Pulmonary (pMDIs and DPIs) and Nasal (Spray) Drug Delivery; workshops featuring research innovation and practical sessions; a lecture session providing an insight into Regulatory Challenges (formulation development, leachables and extractables, current regulatory device challenges, dossier submissions).
Four experts from Valois Pharma and Pfeiffer gave lectures and facilitated workshops :
Guillaume Brouet, Valois Pharma Director Business Development Pulmonary : “Advances in the development of components for portable inhalers”
Hervé Pacaud, Valois Pharma Director, Business Development Pumps: “Rx nasal market and new trends in nasal devices”
Dr Gerallt Williams, Valois Pharma Director, Laboratory Services: “Current Regulatory Device Challenges : a Perspective”.
Matthias Birkhoff, Pfeiffer Pharma Division Vice-President Marketing “New technologies in Liquid Drug Delivery : Preservative Free Ophthalmic Systems”
The Valois Pharma presentations are available on the Valois Pharma website : www.valois.com/pharma/en/publication/publication.php
A significant investment by Pfeiffer and Valois Pharma in India
Pfeiffer and Valois Pharma have been operating in India for the last ten years and have been working closely with the Indian Pharmaceutical Association to make this symposium a success. Pfeiffer and Valois Pharma are now organized under the name of Aptar Pharma India.
Pfeiffer and Valois Pharma are the recognized market leaders in India for both pulmonary and nasal drug delivery devices. Pfeiffer and Valois Pharma continue to expand their activity, leveraging an in-depth network of local partners to forge strong links with a wide range of players in India, including those in research, industry, academia and regulating bodies.
Jointly organizing this 4th symposium in India is part of Pfeiffer and Valois Pharma global strategy to promote and develop nasal and pulmonary drug delivery technology and expertise internationally.